middle.news
Racura Oncology Secures $2.3m Underwriting for Expiring Options
4:43pm on Thursday 28th of May, 2026 AEST
•
Healthcare
Read Story
Racura Oncology Secures $2.3m Underwriting for Expiring Options
4:43pm on Thursday 28th of May, 2026 AEST
Key Points
Underwriting agreement covers 1,838,524 expiring $1.25 options
No underwriting fee from existing supportive shareholder
Raises up to $2.3 million to fund AML, lung cancer, cardioprotection trials
Funds strengthen balance sheet following $22.9 million from exercised options
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE